@cepi.net
Coalition for Epidemic Preparedness Innovations (CEPI). Working to end epidemics & pandemics by developing new vaccines for a safer world. #100DaysMission
@cepi.netA new early-stage trial assessing @ox.ac.uk's Bundibugyo ebolavirus vaccine candidate has launched in Uganda.
The CEPI-funded study is being conducted by MRC/UVRI & LSHTM Uganda Research Unit with @ovg.ox.ac.uk and Pandemic Sciences Institute and the Serum Institute of India manufacturing doses.
@cepi.netCEPI's September newsletter is now available! šļø This month spotlights continued momentum for CEPI 3.0, with $240 million in new funding pledged by partners at UNGA 81. It also features our latest R&D partnerships, new funding opportunities and lots more.
@cepi.netAs global health leaders ready themselves for this yearās World Health Summit Health Summit in Berlin, CEPI invites you to join its official panel discussion, From Crisis Response to Resilience: Innovating for Health Security Beyond Borders.
@cepi.netThree teams will receive a six-month accelerator, including up to US$50,000 in funding each, technical mentorship and access to global health experts, culminating in a showcase in Geneva in May 2027. Deadline: 31 October 2026, 11:59 p.m. CET.
@cepi.netNew funding: The @bioprevail.bsky.social x CEPI Biosecurity Innovation Challenge is seeking practical biosafety and biosecurity innovations to strengthen vaccine R&D and manufacturing during epidemic and pandemic responses, supporting CEPIās 100 Days Mission: bioprevail.org/challenge/bi...
@cepi.netThank you to Ethiopia, Norway and the UK for backing CEPI 3.0.
Read the full announcement to learn more: cepi.net/ethiopia-nor....
@cepi.netAs CEPI CEO Dr Hatchett said: āBy backing CEPI 3.0, Ethiopia, Norway and the UK are showing the kind of foresight and leadership that global health security depends on. Their investments will strengthen the world's disease defences, helping us respond rapidly and equitably to emerging viral threatsā
@cepi.netThe commitments, announced during CEPIās side event at the 81st session of the UN General Assembly, will support CEPI 3.0, the Coalition's 2027ā2031 strategy to systematically reduce the likelihood, impact and cost of epidemics and pandemics.
@cepi.netš Major new funding for CEPI announced today.
Ethiopia, Norway and the UK have pledged a combined US$240 million to support CEPIās five-year plan to transform the worldās ability to prevent and respond to future epidemic and pandemic threats. cepi.net/ethiopia-nor...
@cepi.netGood decisions in an outbreak depend on good evidence. Thatās why CEPI is investing US$3.9 million in three research projects to strengthen understanding of the Bundibugyo ebolavirus (BDBV) outbreak in the DRC, helping guide the response and support clinical trials of BDBV vaccine candidates ā¬ļø
@pandemiccenter.bsky.socialReposted by @cepi.netWeāre thrilled to announce our new cohort of Fellows! Supported by @carnegie.org, this program builds biosecurity expertise by placing Fellows with leading global organizations to reduce biothreats.
Read our full release ā¤µļø
pandemics.sph.brown.edu/news/2026-09...
@cepi.netToday we announced new funding of up to US$8.9 million in Immunoscript Life Science to advance clinical testing of its thermostable next-generation self-amplifying RNA vaccine technology š½
@cepi.netThis week we hosted a landmark pandemic simulation exercise with Indonesia's Ministry of Health to strengthen national and regional readiness against a future āDisease Xā. Discover more:
@cepi.netThe discussion will bring together leaders from government, industry, regulatory agencies and health organisations to explore how long-term partnerships can transform fragmented efforts into collective readiness for the 100 Days Mission.
@cepi.netAs global leaders gather for the UN General Assembly High-Level Meeting on Pandemic Prevention, Preparedness and Response, CEPI invites you to join its flagship side event: Building Crisis-Ready Coalitions: From Fragmentation to Readiness.
Register now: web-eur.cvent.com/event/44c8f5...
@cepi.netCEPI's August newsletter is now available ā¬ļø This edition spotlights CEPIās ongoing efforts to close the mpox vaccine access gap, the latest progress in the fight against Bundibugyo ebolavirusāincluding funding for a fifth vaccine candidate and the initiation of another Phase 1 trialāand lots more.
@cepi.netWe've announced a new US$16.5 million partnership with African biopharmaceutical company Minapharm Group to develop their Bundibugyo vaccine candidate.
The Bundibugyo epidemic in the DRC is the fastest-growing and second-largest Ebola outbreak on record: cepi.net/african-bund...
